Strategic Initiative
Slingshot members are tracking this corporate initiative:
Celldex (CLDX) Agrees to Acquire Privately Held Koltan Pharmaceuticals in All-Stock Deal for up to $235MM
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CLDX |
|
|
Koltan Pharmaceuticals |
|
|
|
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Nov 02, 2016 Projected Implementation: Q4, 2016 Relevance Tracked Until: Q4, 2017
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Acquisition, All Stock Deal, Tyrosine Kinases, Antibody-based Drugs, Ktn3379, Phase 1, Erbb3, Her3, Cancers, Ktn0158, Kit Activation, Tumors Cells, Mast Cells
